Clonal dissemination of Yersinia enterocolitica strains with various susceptibilities to nalidixic acid

Journal of Clinical Microbiology

Volumn 41, Issue 4, 2003, Pages 1769-1771

  Sánchez Céspedes, Javier ^a   Navia, Margarita M ^a   Martínez, Rocío ^b   Orden, Beatriz ^b   Millán, Rosario ^b   Ruiz, Joaquín ^a   Vila, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; CIPROFLOXACIN; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GASTROINTESTINAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; YERSINIA; YERSINIA ENTEROCOLITICA;

ANTI-INFECTIVE AGENTS; BASE SEQUENCE; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; NALIDIXIC ACID; SEQUENCE ANALYSIS, DNA; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; YERSINIA; YERSINIA ENTEROCOLITICA;

EID: 0037390033     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.4.1769-1771.2003     Document Type: Article

References (19)

1. Ackers, M. L., S. Schoenfeld, J. Markman, M. G. Smith, M. A. Nicholson, W. DeWitt, D. N. Cameron, P. M. Griffin, and L. Slutsker. 2000. An outbreak of Yersinia enterocolitica O:8 infections associated with pasteurised milk. J. Infect. Dis. 181:1834-1837.
2. Asensio, A., R. Canton, J. Vaqué, J. Roselló, J. L. Arribas, and the EPINE Work Group. 2002. Utilización de los antimicrobianos en los hospitales españoles (EPINE, 1990-1999). Med. Clin. (Barc.) 118:731-736.
3. Auckenthaler, R., M. Michea-Hamzehpour, and J. C. Pechere. 1986. In vitro activity of newer quinolones against aerobic bacteria. J. Antimicrob. Chemother. 17:29-39.
4. Bottone, E. J. 1997. Yersinia enterocolitica: the charisma continues. Clin. Microbiol. Rev. 10:257-276.
5. Cover, T. L., and R. C. Aber. 1989. Yersinia enterocolitica. N. Engl. J. Med. 321:16-24.
6. Frederiksson-Ahomaa, M., T. Autio, and H. Korkeala. 1999. Efficient subtyping of Yersinia enterocolitica bioserotype 4/O:3 with pulsed-field gel electrophoresis. Lett. Appl. Microbiol. 29:308-312.
7. Gallardo, F., J. Ruiz, F. Marco, K. J. Towner, and J. Vila. 1999. Increase in incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype typhimurium with investigation of molecular epidemiology and mechanisms of resistance. J. Med. Microbiol. 48:367-374.
8. Hosaka, S., M. Uchiyama, M. Ishikawa, T. Akahoshi, H. Kondo, C. Shimauchi, T. Sasahara, and M. Inoue. 1997. Yersinia enterocolitica serotype 0:8 septicemia in an otherwise healthy adult: analysis of chromosome DNA pattern by pulsed-field gel electrophoresis. J. Clin. Microbiol. 35:3346-3347.
9. Lobato, M. J., E. Landeras, M. A. González-Hevia, and M. C. Mendoza. 1998. Genetic heterogeneity of clinical strains of Yersinia enterocolitica traced by ribotyping and relationships between ribotypes, serotypes, and biotypes. J. Clin. Microbiol. 36:3297-3302.
10. Marjai, E., M. Kalman, I. Kajary, A. Belteky, and M. Rodler. 1987. Isolation from food and characterization by virulence test of Yersinia enterocolitica associated with an outbreak. Acta Microbiol. Hung. 34:97-109.
11. Najdenski, H., I. Iteman, and E. Carniel. 1994. Efficient subtyping of pathogenic Yersinia enterocolitica strains by pulsed-field gel electrophoresis. J. Clin. Microbiol. 32:2913-2920.
12. National Committee for Clinical Laboratory Standards. 2001. Performance standard for antimicrobial susceptibility testing. Approved standard M100-S11. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. Navia, M. M., J. Ruiz, A. Ribera, M. T. Jimenez De Anta, and J. Vila. 1999. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii. J. Antimicrob. Chemother. 44:743-748.
14. Ruiz, J., J. Gomez, M. M. Navia, A. Ribera, J. M. Sierra, F. Marco, J. Mensa, and J. Vila. 2002. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 42:257-261.
15. Ruiz, J., F. Marco, P. Goñi, F. Gallardo, J. Mensa, A. Trilla, T. Jiménez de Anta, and J. Vila. 1995. High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 36:737-738.
16. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. E. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
17. Thompson, J. S., and M. J. Gravel. 1986. Family outbreak of gastroenteritis due to Yersinia enterocolitica serotype O:3 from well water. Can. J. Microbiol. 32:700-701.
18. Vila, J., J. Ruiz, F. Marco, A. Barcelo, P. Goñi, E. Giralt, and M. T. Jimenez De Anta. 1994. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob. Agents Chemother. 38:2477-2479.
19. Vila, J., J. Ruiz, and M. Navia. 1999. Molecular bases of quinolone resistance acquisition in gram-negative bacteria. Recent Res. Dev. Antimicrob. Agents Chemother. 3:323-344.